Largest comparison between onset and relapses of acquired thrombotic thrombocytopenic purpura reveals severe neurological involvement and worse analytic parameters at debut

Ann Hematol. 2024 Mar;103(3):725-727. doi: 10.1007/s00277-024-05634-x. Epub 2024 Jan 27.

Abstract

It has been proposed that the onset of Acquired Thrombotic Thrombocytopenic Purpura (iTTP) is more severe than subsequent relapses; however, existing studies have limitations. We conducted a retrospective observational study to compare analytical and clinical severity of onset and relapse aTTP cases between 2012 and 2023. A total of 370 episodes of aTTP were analyzed, comprising 272 at initial diagnosis and 98 relapses. At onset, analytical parameters indicative of severity (low hemoglobin, low platelet count, and increased LDH) were significantly worse; patients had severe neurological symptoms (p<0.001) and ≥ 3 points in the TMA mortality score (p<0.001). In conclusion, the onset of aTTP is associated with worse analytical parameters and severe neurological involvement.

Keywords: Acquired thrombotic thrombocytopenic purpura; Neurological involvement; Onset; Relapse; Severity.

Publication types

  • Observational Study

MeSH terms

  • ADAMTS13 Protein
  • Humans
  • Purpura, Thrombotic Thrombocytopenic* / diagnosis
  • Purpura, Thrombotic Thrombocytopenic* / therapy
  • Recurrence
  • Retrospective Studies

Substances

  • ADAMTS13 Protein

Supplementary concepts

  • Thrombotic thrombocytopenic purpura, acquired